Inventors:
Edward Lane - Bridgeport CT, US
Assignee:
Fairfield Clinical Trials, LLC - Weston CT
International Classification:
A61K031/7048, A61K031/704, A61K031/496, A61K031/4196, A61K031/4178
US Classification:
514028000, 514035000, 514254070, 514383000, 514397000
Abstract:
This invention relates to a method of treating otitis externa, and in particular otitis externa of fungal etiology, using topical medication, including antifungal agents such as, for example fluconazole, voriconazole, itraconazole, clotrimazole, amphotericin B, caspofungin (Cancidas®), micafungin (Mycamine®), terbinafine, naftifine, butenafine, amorolfine, ravuconazole, posaconazole, flucytosine, econazole, enilaconazole, miconazole, oxiconazole, saperconazole, sulconazole, terconazole, tioconazole, nikkomycin Z, anidulafungin (LY303366), nystatin, pimaricin, griseofulvin, ciclopirox, haloprogin, tolnaftate, and undecylenate.